|Bid||59.50 x 0|
|Ask||59.74 x 0|
|Day's Range||59.50 - 61.81|
|52 Week Range||23.88 - 76.68|
|Beta (3Y Monthly)||3.95|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||70.52|
Though marijuana legalization may not be the top overall campaign issue heading into 2020, it remains an important part of many candidates' platforms.
Cannabis Stocks ACB, CRON, APHA, TLRY Trending Lower Today(Continued from Prior Part)Cannabis stocksCannTrust (CTST) was trading about 4.2% lower as of noon ET today, and OrganiGram (OGRMF) was also in the red with a loss of 4%.Canopy Growth
Canadian pot producer Canopy Growth bought another hemp-focused company, a move that could hasten its advance into the newly-legal U.S. market for the plant.
CRON, ACB, CGC, APHA, and Other Cannabis Stocks Trend LowerCannabis sectorThe overall cannabis sector was trading almost flat to negative in the first half of March 21. The Horizons Marijuana Life Science ETF (HMMJ) was flat a 23.1 Canadian dollars
Canopy Growth Sets Its Eyes on the US Market(Continued from Prior Part)Hemp’s potential Previously in this series, we discuss some of the product research from ebbu—Canopy Growth’s (WEED) (CGC) US subsidiary. With the announcement of the
Canopy Growth Corp (NYSE: CGC)'s foray into the U.S. hemp industry is speeding up with another acquisition. One of the largest cannabis companies in the world said Thursday that acquired hemp company AgriNextUSA. Following the acquisition, Geoff Whaling — AgriNextUSA CEO and chairman of the National Hemp Association — will be appointed to Canopy Growth's U.S. division as strategic adviser for hemp and CBD.
March Update: Analysts’ Ratings for TLRY, IIPR, and SPRWF(Continued from Prior Part)Innovative Industrial PropertiesLast week, Innovative Industrial Properties (IIPR) reported its earnings. The company reported sales of $4.7 million, which more
Canopy Growth Sets Its Eyes on the US MarketNew acquisitionOn March 20, Canopy Growth (WEED) (CGC) announced that it signed a multiyear extraction agreement with HollyWeed. The company is back in the news with yet another event. Early on March 21,
March Update: Analysts’ Ratings for TLRY, IIPR, and SPRWF(Continued from Prior Part)Tilray’s disappointing earningsTilray (TLRY) just reported its earnings earlier this week. Since then, the stock hasn’t moved much. The company reported total
March Update: Analysts’ Ratings for TLRY, IIPR, and SPRWFAnalysts’ ratings Cannabis stocks have been highly volatile. Playing the volatility game can be risky. Investors (HMMJ) could use analysts’ consensus view on a stock to gauge and
Hemp pioneer Geoff Whaling to join Canopy Growth USA as Strategic Advisor, Hemp and CBD in addition to being the co-Founder and President of Hemp Developments LLC. SMITHS FALLS, ON, March 21, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO) (CGC) is pleased to announce today it has acquired AgriNextUSA, a hemp enterprise led by CEO Geoff Whaling, that has been at the forefront of hemp advocacy and building a vibrant hemp sector in the USA. The acquisition will accelerate Canopy Growth's entry into key American jurisdictions as regulations surrounding the full use of hemp as a crop begin to be implemented, thanks in part to the recently enacted 2018 US Farm Bill.
CORAL GABLES, FL / ACCESSWIRE / March 20, 2019 / The marijuana stock market has been historically volatile for the last few months. Following the introduction of recent legislation in support of cannabis legalization, the marijuana industry has picked up speed as a result of increasing public support. Transcanna Holdings Inc (TCAN.CN), OrganiGram Holdings Inc (OGRMF), Cresco Labs Inc (CRLBF), and Canopy Growth Corp (CGC) (WEED.TO) are four cannabis companies worth looking into.
Cannabis Sector Is in the Red on March 20(Continued from Prior Part)The gainersNot all cannabis sector (MJ) stocks suffered losses on March 20. Canopy Growth (WEED) (CGC) was trading in the green. Its stock rose nearly 2.3% after the company
Canopy Growth Rises on News of Extraction Agreement(Continued from Prior Part)Value-added products Canopy Growth (WEED) (CGC) aims to launch an array of products to serve a variety of customer tastes and preferences. These products will
Per the terms of the agreement, HollyWeed will process Canopy-supplied dried cannabis flower in its Victoria, British Columbia manufacturing facility. In turn, HollyWeed will supply Canopy with oil and resin extracted from the source material. The partnership is expected to expand Canopy’s in-house capacity.
Canopy Growth Rises on News of Extraction AgreementCanopy Growth’s new agreement On March 20, Canopy Growth (CGC) (WEED) announced that it had entered into a multiyear extraction and processing agreement with HollyWeed North Cannabis. HollyWeed
HOUSTON, TX / ACCESSWIRE / March 20, 2019 / Analysts at Jefferies say the cannabis industry could reach $130 billion by 2029. "This assumes full U.S. federal legalization, full recreational and medical ...
What to Expect from Cronos Group’s Q4 Earnings(Continued from Prior Part)ProfitabilityPreviously in this series, we saw that Cronos Group (CRON) is expected to report sales growth of almost 459% year-over-year in the fourth quarter. Let’s
What to Expect from Cronos Group’s Q4 EarningsFourth-quarter earnings Cronos Group (CRON) is scheduled to report its fourth-quarter and fiscal 2018 earnings on March 26 before the market opens. The company will hold an earnings call on the same
SMITHS FALLS, ON and VICTORIA, BC , March 20, 2019 /CNW/ - Canopy Growth Corporation (WEED.TO) (CGC) ("Canopy Growth" or the "Company") and HollyWeed Manufacturing & Extracts Inc. are pleased to announce today they have entered into a multi-year processing and extraction agreement. HollyWeed North Cannabis Inc., the parent company of HollyWeed Manufacturing & Extracts Inc., is a female-led, LGBTQ2-positive company based in British Columbia that operates several subsidiaries specializing in the growth, manufacturing, licensing, and production of cannabis and other pharmaceutical grade products.
Sales growth and partnerships aside, pot stock Tilray leaves a lot to be desired.